Metropolitan Digital

Men's Weekly


.

FDA’s new regulations underscore the complexity around screening for women with dense breasts

  • Written by Nancy Kressin, Emeritus Professor of Medicine, Boston University
FDA’s new regulations underscore the complexity around screening for women with dense breastsBreast density raises the risk of breast cancer and can also make it more difficult for breast cancer to be detected.picture alliance/Getty Images

The Food and Drug Administration implemented a rule to go into effect on Sept. 10, 2024, requiring mammography facilities to notify women about their breast density. The goal is to ensure that women...

Read more: FDA’s new regulations underscore the complexity around screening for women with dense breasts

Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more